Tracking the migration of cardially delivered therapeutic stem cells in vivo: State of the art

Regenerative Medicine

Volumn 4, Issue 3, 2009, Pages 407-422

  Nyolczas, N ^a   Charwat, S ^a   Posa, A ^a   Hemetsberger, R ^a   Pavo, N ^a   Hemetsberger, H ^a   Pavo, I J ^a   Glogar, D ^a   Maurer, G ^a   Gyöngyösi, Mariann ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

In vivo tracking; MRI; PET; Reporter gene; Stem cell; Transfection

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM;

BIOLUMINESCENCE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CELL THERAPY; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; ECHOCARDIOGRAPHY; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HUMAN; IMAGING; IN VIVO STUDY; LENTIVIRINAE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPORTER GENE; REVIEW; SCINTIGRAPHY; STEM CELL TRANSPLANTATION; ANIMAL; CELL MOTION; CYTOLOGY; HEART MUSCLE; LUMINESCENCE; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; STEM CELL;

ANIMALS; CELL MOVEMENT; GENES, REPORTER; HUMANS; LUMINESCENT MEASUREMENTS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 68049129736     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.09.14     Document Type: Review

References (58)

1. Orlic D, Kajstura J, Chimenti S et al.: Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705 (2001).
2. Kocher AA, Schuster MD, Szabolcs MJ et al.: Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430-436 (2001).
3. Strauer BE, Brehm M, Zeus T et al.: Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106, 1913-1918 (2002).
4. Schächinger V, Assmus B, Britten MB et al.: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Final one-year results of the TOPCARE-AMI trial. J. Am. Coll. Cardiol. 44, 1690-1699 (2004).
5. Wollert KC, Meyer GP, Lotz J et al.: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-148 (2004).
6. Gyöngyösi M, Lang I, Dettke M et al.: Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study. Nat. Clin. Pract. Cardiovasc. Med. 6, 70-81 (2009).
7. Beeres SL, Bengel FM, Bartunek J et al.: Role of imaging in cardiac stem cell therapy. J. Am. Coll. Cardiol. 49(11), 1137-1148 (2007).
8. Daldrup-Link HE, Rudelius M, Oostendorp RAJ et al.: Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 228, 760-767 (2003).
9. Giesel FL, Stroick M, Griebe M et al.: Gadofluorine M uptake in stem cells as a new magnetic resonance imaging tracking method. An in vitro and in vivo study. Invest. Radiol. 41, 868-873 (2006).
10. Modo M, Cash D, Mellodew K et al.: Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 17, 803-811 (2002).
11. Hoshino K, Ly HQ, Frangioni JV, Hajjar RJ: In vivo tracking in cardiac stem cell-based therapy. Prog. Cardiovasc. Dis. 49(6), 414-420 (2007).
12. Modo M, Beech JS, Meade TJ et al.: A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke. Neuroimage (2008) (Epub ahead of print).
13. Bulte JW, Kraitchman DL: Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 17, 484-499 (2004).
14. Kustermann E, Roell W, Breitbach M et al.: Stem cell implantation in ischemic mouse heart: a high-resolution magnetic resonance imaging investigation. NMR Biomed. 18(6), 362-370 (2005).
15. Penn MS: Cell-based gene therapy for the prevention and treatment of cardiac dysfunction. Nat. Clin. Pract. Cardiovasc. Med. 4(Suppl.), S83-S88 (2007).
16. Kraitchman DL, Bulte JWM: Imaging of stem cells using MRI. Basic Res. Cardiol. 103, 105-113 (2008).
17. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP: MRI detection of single particles for cellular imaging. Proc. Natl Acad. Sci. USA 101(30), 10901-10906 (2004).
18. Kraitchman DL, Heldman AW, Atalar E et al.: In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107, 2290-2293 (2003).
19. Hill JM, Dick AJ, Raman VK et al.: Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 108, 1009-1014 (2003).
20. Amsalem Y, Mardor Y, Feinberg MS et al.: Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 116(Suppl. 11), I38-I45 (2007).
21. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM: Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat. Med. 7, 1241-1244 (2001).
22. Zhu J, Zhou L, XingWu F: Tracking neural stem cells in patients with brain trauma. N. Engl. J. Med. 355(22), 2376-2378 (2006).
23. de Vries IJ, Lesterhuis WJ, Barentsz JO et al.: Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 23(11), 1407-1413 (2005).
24. Morawski AM, Lanza GA, Wickline SA: Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr. Opin. Biotechnol. 16, 89-92 (2005).
25. Liang HD, Blomley MJ: The role of ultrasound in molecular imaging. Br. J. Radiol. 76(Spec No 2), S140-S508 (2003).
26. Kofidis T, Lebl DR, Swijnenburg RJ, Greeve JM, Klima U, Robbins RC: Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. Eur. J. Cardiothorac. Surg. 29(1), 50-55 (2006).
27. Bengel FM: Nuclear imaging in cardiac cell therapy. Heart Fail. Rev. 11(4), 325-332 (2006).
28. Frangioni JV, Hajjar RJ: In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 110(21), 3378-3383 (2004).
29. Acton PD, Zhou R: Imaging reporter genes for cell tracking with PET and SPECT. Q. J. Nucl. Med. Mol. Imaging 49(4), 349-360 (2005).
30. Gambhir SS, Herschman HR, Cherry SR et al.: Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2, 118-1388 (2000).
31. Ray P, Wu AM, Gambhir SS: Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of l iving mice. Cancer Res. 63, 1160-1165 (2003).
32. Miyagawa M, Anton M, Haubner R et al.: PET of cardiac transgene expression: comparison of 2 approaches based on herpesviral thymidine kinase reporter gene. J. Nucl. Med. 45, 1917-1923 (2004).
33. Gyöngyösi M, Blanco J, Marian T et al.: Serial non-invasive in vivo positron emmission tomographyc (PET) tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ. Cardiovascular Imaging 1, 94-103 (2008).
34. Wu JC: Molecular imaging. Antidote to cardiac stem cell controversy. J. Am. Coll. Cardiol. 52, 1161-1164 (2008).
35. Krishnan M, Park JM, Cao F et al.: Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. Faseb J. 20(1), 106-108 (2006).
36. Cao F, Lin S, Xie X et al.: In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113, 1005-1014 (2006).
37. Wu JC, Chen IY, Sundaresan G et al.: Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 108, 1302-1305 (2003).
38. Barton KN, Tyson D, Stricker H et al.: GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo. Mol. Ther. 8(3), 508-518 (2003).
39. Groot-Wassink T, Aboagye EO, Wang Y, Lemoine NR, Reader AJ, Vassaux G: Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol. Ther. 9(3), 436-442 (2004).
40. Niu G, Gaut AW, Ponto LL et al.: Multimodality noninvasive imaging of gene transfer using the human sodium iodide symporter. J. Nucl. Med. 45(3), 445-449 (2004).
41. Swijnenburg RJ, van der Bogt KEA, Sheikh AY, Cao F, Wu JC: Clinical hurdles for the transplantation of cardiomyocytes derived from human embryonic stem cells: role of molecular imaging. Curr. Opin. Biotechnol. 18, 38-45 (2007).
42. Carr CA, Stuckey DJ, Tatton L et al.: Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study. Am. J. Physiol. Heart Circ. Physiol. 295, 533-542 (2008).
43. Guo C, Haider HKh, Wang C et al.: Myoblast transplantation for cardiac repair: from automyoblast to allomyoblast transplantation. Ann. Thorac. Surg. 86, 1841-1848 (2008).
44. 18F-FDG-labelled progenitor cell therapy for acute myocardial infarction. J. Nucl. Med. 48, 1708-1714 (2007).
45. Barbash IM, Chouraqui P, Baron J et al.: Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108(7), 863-868 (2003).
46. Aicher A, Brenner W, Zuhayra M et al.: Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107(16), 2134-2139 (2003).
47. 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl. Med. Commun. 24(11), 1149-1154 (2003).
48. Rodrigquez-Porcel M, Brinton TJ, Chen IY et al.: Reporter gene imaging following percutaneous delivery in swine model toward clinical applications. J. Am. Coll. Cardiol. 51, 595-597 (2008).
49. Bengel FM, Anton M, Richter T et al.: Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer. Circulation 108, 2127-2133 (2003).
50. Hofmann M, Wollert KC, Meyer GP et al.: Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111(17), 2198-2202 (2005).
51. Penicka M, Widimsky P, Kobylka P, Kozak T, Lang O: Images in cardiovascular medicine. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction. Circulation 112(4), e63-e65 (2005).
52. 18F-FDG-labelled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J. Nucl. Med. 47, 1295-1301 (2006).
53. Ebert SN, Taylor DG, Nguyen HL et al.: Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques. Stem Cells 25, 2936-2944 (2007).
54. Mani V, Adler E, Briley-Saebo KC et al.: Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction. Magn. Reson. Med. 60, 73-81 (2008).
55. Kraitchman DL, Tatsumi M, Gilson WD et al.: Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112, 1451-1461 (2005).
56. + hematopoietic progenitor cells in a rat myocardial infarction model. J. Nucl. Med. 45, 512-518 (2004).
57. Hou D, Youssef EAS, Brinton TJ et al.: Radiolabeled cell distribution after intramyocardial, intracoronary, and intertitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112, I150-I156 (2005).
58. Freyman T, Polin G, Osman H et al.: A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur. Heart J. 27, 1114-1122 (2006).